Zoe Barter

1.3k total citations
17 papers, 1.1k citations indexed

About

Zoe Barter is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Zoe Barter has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 9 papers in Oncology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Zoe Barter's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Zoe Barter is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Zoe Barter collaborates with scholars based in United Kingdom, United States and France. Zoe Barter's co-authors include Amin Rostami‐Hodjegan, K Rowland‐Yeo, Geoffrey T. Tucker, John C. Lipscomb, Karen Rowland Yeo, Sibylle Neuhoff, Masoud Jamei, Brian G. Lake, Alan R. Boobis and David Carlile and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Clinical Pharmacokinetics and Drug Metabolism and Disposition.

In The Last Decade

Zoe Barter

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zoe Barter United Kingdom	14	586	473	247	166	136	17	1.1k
Eva Gil Berglund Sweden	13	466 0.8×	385 0.8×	259 1.0×	174 1.0×	154 1.1×	19	1.1k
Yuan Chen United States	17	520 0.9×	537 1.1×	269 1.1×	261 1.6×	109 0.8×	62	1.4k
K Rowland‐Yeo United Kingdom	16	702 1.2×	519 1.1×	327 1.3×	285 1.7×	281 2.1×	22	1.6k
Lisa M. Almond United Kingdom	17	327 0.6×	324 0.7×	259 1.0×	158 1.0×	142 1.0×	34	1.1k
Chie Emoto United States	24	667 1.1×	453 1.0×	384 1.6×	202 1.2×	270 2.0×	70	1.5k
Kirstin Thelen Germany	20	386 0.7×	324 0.7×	259 1.0×	191 1.2×	186 1.4×	26	1.3k
Takafumi Iwatsubo Japan	18	688 1.2×	524 1.1×	140 0.6×	264 1.6×	155 1.1×	33	1.2k
Hayley S. Brown United Kingdom	12	772 1.3×	478 1.0×	118 0.5×	295 1.8×	80 0.6×	18	1.3k
Martin K. Bayliss United Kingdom	18	613 1.0×	414 0.9×	128 0.5×	344 2.1×	113 0.8×	32	1.4k
Matthew G. Soars United States	20	979 1.7×	785 1.7×	288 1.2×	378 2.3×	108 0.8×	32	1.6k

Countries citing papers authored by Zoe Barter

Since Specialization

Citations

This map shows the geographic impact of Zoe Barter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoe Barter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoe Barter more than expected).

Fields of papers citing papers by Zoe Barter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoe Barter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoe Barter. The network helps show where Zoe Barter may publish in the future.

Co-authorship network of co-authors of Zoe Barter

This figure shows the co-authorship network connecting the top 25 collaborators of Zoe Barter. A scholar is included among the top collaborators of Zoe Barter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoe Barter. Zoe Barter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Abla, Nada, Eleanor Howgate, Karen Rowland Yeo, et al.. (2023). Development and application of a PBPK modeling strategy to support antimalarial drug development. CPT Pharmacometrics & Systems Pharmacology. 12(9). 1335–1346. 13 indexed citations

Michon, Ingrid, et al.. (2023). Physiologically Based Pharmacokinetic Modeling for Maribavir to Inform Dosing in Drug‐Drug Interaction Scenarios with CYP3A4 Inducers and Inhibitors. The Journal of Clinical Pharmacology. 64(5). 590–600. 6 indexed citations

Sun, Lei, Zoe Barter, Lisa Von Moltke, & Karen Rowland Yeo. (2021). Using physiologically‐based pharmacokinetic modeling for predicting the effects of hepatic impairment on the pharmacokinetics of olanzapine and samidorphan given as a combination tablet. CPT Pharmacometrics & Systems Pharmacology. 10(9). 1071–1080. 8 indexed citations

Ke, Alice, Zoe Barter, K Rowland‐Yeo, & Lisa M. Almond. (2016). Towards a Best Practice Approach in PBPK Modeling: Case Example of Developing a Unified Efavirenz Model Accounting for Induction of CYPs 3A4 and 2B6. CPT Pharmacometrics & Systems Pharmacology. 5(7). 367–376. 44 indexed citations

Gibson, Christopher R., Ping Lü, Zoe Barter, et al.. (2013). Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans. Xenobiotica. 43(12). 1027–1036. 15 indexed citations

Barter, Zoe, Geoffrey T. Tucker, & K Rowland‐Yeo. (2013). Differences in Cytochrome P450-Mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically Based Pharmacokinetic Modelling. Clinical Pharmacokinetics. 52(12). 1085–1100. 101 indexed citations

Neuhoff, Sibylle, Karen Rowland Yeo, Zoe Barter, et al.. (2013). Application of permeability-limited physiologically-based pharmacokinetic models: Part I–digoxin pharmacokinetics incorporating P-glycoprotein-mediated efflux. Journal of Pharmaceutical Sciences. 102(9). 3145–3160. 57 indexed citations

Neuhoff, Sibylle, Karen Rowland Yeo, Zoe Barter, et al.. (2013). Application of permeability‐limited physiologically-based pharmacokinetic models: Part II-prediction of p‐glycoprotein mediated drug–drug interactions with digoxin. Journal of Pharmaceutical Sciences. 102(9). 3161–3173. 53 indexed citations

Jamei, Masoud, Sibylle Neuhoff, Zoe Barter, et al.. (2013). A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine. Clinical Pharmacokinetics. 53(1). 73–87. 138 indexed citations

10.

Salem, Farzaneh, Trevor N. Johnson, Zoe Barter, J. Steven Leeder, & Amin Rostami‐Hodjegan. (2013). Age Related Changes in Fractional Elimination Pathways for Drugs: Assessing the Impact of Variable Ontogeny on Metabolic Drug-Drug Interactions. The Journal of Clinical Pharmacology. 53(8). 857–865. 52 indexed citations

11.

Yeo, Karen Rowland, et al.. (2011). Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model. Xenobiotica. 41(8). 623–638. 50 indexed citations

12.

Crewe, H.K., Zoe Barter, Karen Rowland Yeo, & Amin Rostami‐Hodjegan. (2011). Are there differences in the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9? A systematic investigation into inter‐system extrapolation factors. Biopharmaceutics & Drug Disposition. 32(6). 303–318. 35 indexed citations

13.

Ohtani, Hisakazu, Zoe Barter, Tsuyoshi Minematsu, et al.. (2011). Bottom‐up modeling and simulation of tacrolimus clearance: prospective investigation of blood cell distribution, sex and CYP3A5 expression as covariates and assessment of study power. Biopharmaceutics & Drug Disposition. 32(9). 498–506. 7 indexed citations

14.

Barter, Zoe, et al.. (2010). Determination of a quantitative relationship between hepatic CYP3A5*1/*3 and CYP3A4 expression for use in the prediction of metabolic clearance in virtual populations. Biopharmaceutics & Drug Disposition. 31(8-9). 516–532. 31 indexed citations

15.

Barter, Zoe, et al.. (2008). Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling. Drug Metabolism and Disposition. 36(12). 2405–2409. 104 indexed citations

16.

Barter, Zoe, et al.. (2007). Disparity in Holoprotein/Apoprotein Ratios of Different Standards Used for Immunoquantification of Hepatic Cytochrome P450 Enzymes. Drug Metabolism and Disposition. 35(10). 1733–1736. 15 indexed citations

17.

Barter, Zoe, Martin K. Bayliss, Philippe Beaune, et al.. (2006). Scaling Factors for the Extrapolation of In Vivo Metabolic Drug Clearance From In Vitro Data: Reaching a Consensus on Values of Human Micro-somal Protein and Hepatocellularity Per Gram of Liver. Current Drug Metabolism. 8(1). 33–45. 347 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact